4 November 2004
NEWS Contact: Charles Pucie
For Immediate Release 301-402-5311
STEPHANIE JAMES JOINS FOUNDATION FOR NIH
AS ASSOCIATE DIRECTOR FOR SCIENCE
GRAND CHALLENGES IN GLOBAL HEALTH INITIATIVE
Stephanie L. James, Ph.D., a leader in
research on infectious diseases of global
health importance, has joined the staff of
the Foundation for the National Institutes
of Health as associate director for science
for the Grand Challenges in Global Health
initiative, it was announced today. This
innovative grant-making program which
focuses on increasing research on
diseases of the developing world is
managed and administered by the Foundation for NIH and supported
by a $200 million grant from the Bill & Melinda Gates
Foundation.
Prior to joining the Foundation for NIH, Dr. James served
for 11 years as chief of the Parasitology and International
Programs Branch, Division of Microbiology and Infectious Diseases,
National Institute of Allergy and Infectious Diseases (NIAID).
NIAID is a component of the National Institutes of Health
(NIH). She subsequently was deputy director of The Ellison
Medical Foundation for three years.
Dr. James received her Ph.D. in microbiology at Vanderbilt
University, and conducted her dissertation research in the
area of immunoparasitology. She continued post-doctoral studies
first in the Department of Medicine at Harvard University
and later in the Laboratory of Parasitic Diseases, NIAID.
She subsequently established a research laboratory in the
Departments of Medicine and Microbiology at the George Washington
University Medical Center, where she pursued studies on schistosomiasis
and macrophage biology under funding from the NIAID, the Edna
McConnell Clark Foundation, the National Science Foundation,
and the World Health Organization. In 1987, Dr. James returned
to the extramural component of NIAID as Parasitology Program
Officer, and became Branch Chief in 1991. For several years
she maintained an affiliation with the NIAID intramural Laboratory
of Parasitic Diseases, where she continued research on protective
immunity against schistosomiasis and other parasitic diseases.
While at NIAID, Dr. James was responsible for programmatic
development of the International Centers for Tropical Disease
Research network, the Tropical Medicine Research Centers,
and the International Centers for Excellence in Research.
She co-authored the NIAID Research Plan for Malaria Vaccine
Development, and created many of its component research initiatives.
She was also involved in the formation of the international
Multilateral Initiative on Malaria, and participated in its
Task Force for Research Capability Strengthening in Africa.
She received the NIH Director's Award in 1993 for leadership
in establishing the International Centers for Tropical Disease
Research, and in 1999 for leadership in advancing collaborative
malaria research through the Multilateral Initiative on Malaria.
Dr. James participated in a number of trans-governmental and
international activities on emerging infectious diseases,
contributing to the 1995 CISET report "Infectious Disease-A
Global Threat", the 1996 "NIAID Research Agenda for Emerging
Infectious Diseases", the "Emerging Infectious Diseases and
Global Health" section of the 2000 NIAID Strategic Plan, and
the 2001 "NIAID Global Health Research Plan for HIV/AIDS,
Malaria, and Tuberculosis." During that time, she also served
as Coordinator of the Microbiology Program, and as acting
Deputy Director of the Division of Microbiology and Infectious
Diseases.
In 2001, she moved to The Ellison Medical Foundation, where
she directed the Global Infectious Disease program, established
to enhance innovative research on parasitic and infectious
diseases of major global public health importance. As the
deputy director, she was also responsible for many aspects
of foundation management and operations.
She has served on advisory committees for the World Health
Organization, the Burroughs-Wellcome Fund, and the U.S. Agency
for International Development, among others. In 1998, she
was elected President of the American Society of Tropical
Medicine and Hygiene.
The Grand Challenges in Global Health initiative supports
research on critical scientific and technological problems
that, if solved, could lead to important advances against
diseases of the developing world. The initiative currently
focuses on 14 challenges, including the need for vaccines
that do not require refrigeration and for new strategies to
prevent insects from transmitting disease. The first round
of grants to support research on these challenges is expected
to be announced in early 2005. For more detailed information
on the Grand Challenges initiative, including descriptions
of the first 14 Grand Challenges, visit Grand
Challenges in Global Health
Posted November 9, 2004
|